Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-tsha
/
Taysha Gene Therapies Inc
TSHA
Add to Watchlist
6.650
USD
-0.160
-2.35%
Close 07/01, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/02, 09:30 (ET)
2.13B
Market Cap
Loss
P/E TTM
Taysha Gene Therapies Inc
6.650
-0.160
-2.35%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Manning (Paul B.)
8.91%
RA Capital Management, LP
8.20%
Avoro Capital Advisors LLC
6.49%
Morgan Stanley & Co. LLC
6.21%
BlackRock Institutional Trust Company, N.A.
5.76%
Other
64.43%
Shareholders
Shareholders
Proportion
Manning (Paul B.)
8.91%
RA Capital Management, LP
8.20%
Avoro Capital Advisors LLC
6.49%
Morgan Stanley & Co. LLC
6.21%
BlackRock Institutional Trust Company, N.A.
5.76%
Other
64.43%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
30.02%
Investment Advisor
26.55%
Hedge Fund
15.84%
Research Firm
12.51%
Individual Investor
10.08%
Venture Capital
8.20%
Pension Fund
1.46%
Sovereign Wealth Fund
0.64%
Corporation
0.53%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
369
287.49M
100.06%
+5.52M
2025Q4
332
268.88M
98.16%
-15.50M
2025Q3
289
260.55M
95.12%
+66.39M
2025Q2
275
201.11M
79.83%
-18.39M
2025Q1
280
208.55M
85.47%
-19.89M
2024Q4
274
206.61M
100.79%
-12.49M
2024Q3
266
194.14M
94.73%
-23.74M
2024Q2
250
196.13M
97.09%
+4.27M
2024Q1
251
185.84M
99.33%
-1.52M
2023Q4
229
175.44M
93.86%
-4.17M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Manning (Paul B.)
25.60M
9.35%
+750.00K
+3.02%
May 30, 2025
RA Capital Management, LP
23.56M
8.6%
--
--
Sep 30, 2025
Avoro Capital Advisors LLC
21.70M
7.92%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
19.08M
6.97%
+4.42M
+30.12%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
15.03M
5.49%
+2.94M
+24.29%
Sep 30, 2025
RTW Investments L.P.
24.35M
8.89%
-667.29K
-2.67%
Sep 30, 2025
Vestal Point Capital, LP
5.50M
2.01%
+2.50M
+83.33%
Sep 30, 2025
Fidelity Management & Research Company LLC
14.59M
5.33%
-1.03M
-6.62%
Sep 30, 2025
Goldman Sachs & Company, Inc.
13.20M
4.82%
+676.68K
+5.40%
Sep 30, 2025
State Street Investment Management (US)
7.24M
2.64%
+2.10M
+40.83%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Neuroscience and Healthcare ETF
1.83%
Virtus LifeSci Biotech Clinical Trials ETF
1.27%
Texas Capital Texas Small Cap Equity Index ETF
0.47%
State Street SPDR S&P Biotech ETF
0.29%
iShares Micro-Cap ETF
0.2%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
Vanguard US Momentum Factor ETF
0.13%
Invesco Nasdaq Biotechnology ETF
0.13%
ProShares Ultra Nasdaq Biotechnology
0.13%
Goldman Sachs Innovate Equity ETF
0.1%
View more
iShares Neuroscience and Healthcare ETF
Proportion
1.83%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
1.27%
Texas Capital Texas Small Cap Equity Index ETF
Proportion
0.47%
State Street SPDR S&P Biotech ETF
Proportion
0.29%
iShares Micro-Cap ETF
Proportion
0.2%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.18%
Vanguard US Momentum Factor ETF
Proportion
0.13%
Invesco Nasdaq Biotechnology ETF
Proportion
0.13%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.13%
Goldman Sachs Innovate Equity ETF
Proportion
0.1%